Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis
- PMID: 26870930
- PMCID: PMC4955833
- DOI: 10.1055/s-0035-1571272
Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis
Abstract
Nonalcoholic fatty liver disease represents a wide spectrum of conditions and is currently the most common form of chronic liver disease affecting both adults and children in the United States and many other parts of the world. Great effort has been focused on the development of novel therapies for those patients with the more advanced forms of the disease, in particular those with nonalcoholic steatohepatitis (NASH) and liver fibrosis that can be associated with significant morbidity and mortality. In this review, the authors focus on the role of cell death and sterile inflammatory pathways as well as the self-perpetuating deleterious cycle they may trigger as novel therapeutic targets for the treatment of fibrotic NASH.
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Figures
Similar articles
-
Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease.Semin Liver Dis. 2016 Feb;36(1):69-86. doi: 10.1055/s-0036-1571296. Epub 2016 Feb 12. Semin Liver Dis. 2016. PMID: 26870934 Review.
-
Foresight regarding drug candidates acting on the succinate-GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment.Biomed Pharmacother. 2021 Dec;144:112298. doi: 10.1016/j.biopha.2021.112298. Epub 2021 Oct 12. Biomed Pharmacother. 2021. PMID: 34649219 Review.
-
Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution.Trends Pharmacol Sci. 2018 Apr;39(4):387-401. doi: 10.1016/j.tips.2018.01.003. Epub 2018 Feb 27. Trends Pharmacol Sci. 2018. PMID: 29499974 Review.
-
Macrophages in Nonalcoholic Fatty Liver Disease: A Role Model of Pathogenic Immunometabolism.Semin Liver Dis. 2017 Aug;37(3):189-197. doi: 10.1055/s-0037-1604480. Epub 2017 Aug 28. Semin Liver Dis. 2017. PMID: 28847030 Review. No abstract available.
-
Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD).Methods Mol Biol. 2021;2310:201-246. doi: 10.1007/978-1-0716-1433-4_12. Methods Mol Biol. 2021. PMID: 34096005 Free PMC article. Review.
Cited by
-
Distinct Types of Cell Death and Implications in Liver Diseases: An Overview of Mechanisms and Application.J Clin Transl Hepatol. 2023 Nov 28;11(6):1413-1424. doi: 10.14218/JCTH.2023.00132. Epub 2023 Jul 24. J Clin Transl Hepatol. 2023. PMID: 37719956 Free PMC article. Review.
-
Efferocytosis in liver disease.JHEP Rep. 2023 Nov 16;6(1):100960. doi: 10.1016/j.jhepr.2023.100960. eCollection 2024 Jan. JHEP Rep. 2023. PMID: 38234410 Free PMC article. Review.
-
Magnetic-Assisted Treatment of Liver Fibrosis.Cells. 2019 Oct 19;8(10):1279. doi: 10.3390/cells8101279. Cells. 2019. PMID: 31635053 Free PMC article. Review.
-
FOSL2 deficiency delays nonalcoholic steatohepatitis progression by regulating LY6D-mediated NLRP3 activation.Hum Cell. 2022 Nov;35(6):1752-1765. doi: 10.1007/s13577-022-00760-y. Epub 2022 Aug 5. Hum Cell. 2022. PMID: 35930135
-
The Role of NLRP3 Inflammasome in Radiation-Induced Cardiovascular Injury.Front Cell Dev Biol. 2020 Mar 12;8:140. doi: 10.3389/fcell.2020.00140. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32226786 Free PMC article. Review.
References
-
- Levene AP, Goldin RD. The epidemiology, pathogenesis and histopathology of fatty liver disease. Histopathology. 2012;61(2):141–152. - PubMed
-
- Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274–285. - PubMed
-
- Brunt EM, Neuschwander-Tetri BA, Oliver D, Wehmeier KR, Bacon BR. Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens. Hum Pathol. 2004;35(9):1070–1082. - PubMed
-
- Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129(1):113–121. - PubMed
-
- Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116(6):1413–1419. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical